Valid number
Dropdown
Select your product of interest

Thank you! Your request has been received.

A member of our team will reach out to you shortly,
Oops! Something went wrong while submitting the form.
+

Featured

BioNTech to Acquire CureVac in $1.25 Billion All-Stock Acquisition

BioNTech, a global immunotherapy company, announced its intent to acquire CureVac, a clinical-stage biotech company focused on mRNA-based therapies, i...

June 12, 2025

May 2024

BioNTech to Acquire CureVac in $1.25 Billion All-Stock Acquisition
BioNTech, a global immunotherapy company, announced its intent to acquire CureVac, a clinical-stage biotech company focused on mRNA-based therapies, i...
June 12, 2025
Quell Therapeutics and AstraZeneca Advance CAR-Treg Cell Therapy for Inflammatory Bowel Disease
Quell Therapeutics announced that AstraZeneca has exercised its option to license a lead Treg cell therapy candidate from their joint Inflammatory Bow...
June 10, 2025
Sanofi Acquires Vigil Neuroscience to Expand Alzheimer's Disease Pipeline
Sanofi announced its acquisition of Vigil Neuroscience, a clinical-stage biotechnology company focused on neurodegenerative diseases. This acquisitio...
May 22, 2025
CRISPR and Sirius Therapeutics Partner to Develop siRNA Therapies for Thromboembolic Disorders
CRISPR Therapeutics and Sirius Therapeutics announced a multi-target collaboration to co-develop and co-commercialize SRSD107, a long-acting siRNA the...
May 20, 2025

April 2024

Carlyle and SK Capital Complete Acquisition of bluebird bio
bluebird bio, Inc. announced that it has received all necessary regulatory approvals for its acquisition by Carlyle and SK Capital. The merger is exp...
May 6, 2025
Repare Therapeutics Out-Licenses Discovery Platforms to DCx Biotherapeutics
Repare Therapeutics announced it out-licensed its discovery platforms, including the SNIPRx platform and related intellectual property, to DCx Biother...
May 2, 2025

Latest Merger & Acquisitions

BioNTech to Acquire CureVac in $1.25 Billion All-Stock Acquisition
June 12, 2025
Quell Therapeutics and AstraZeneca Advance CAR-Treg Cell Therapy for Inflammatory Bowel Disease
June 10, 2025
Sanofi Acquires Vigil Neuroscience to Expand Alzheimer's Disease Pipeline
May 22, 2025
CRISPR and Sirius Therapeutics Partner to Develop siRNA Therapies for Thromboembolic Disorders
May 20, 2025
Carlyle and SK Capital Complete Acquisition of bluebird bio
May 6, 2025
Repare Therapeutics Out-Licenses Discovery Platforms to DCx Biotherapeutics
May 2, 2025

Empowering Life Sciences with
Advanced AI Solutions.

Book A Demo
HomeKnolsightsContact UsPricing
One Research Ct, Suite 450 Rockville, MD, 20850
info@pienomial.com
+91 9876543210
Copyright © 2025. All rights reserved
AboutTerms of ServicePrivacy Policy
Home/KnloSights/Mregers And Acquisitions